Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 May;103(5):291-304.
doi: 10.1016/j.contraception.2021.01.017. Epub 2021 Feb 3.

Systemic hormonal contraception initiation after abortion: A systematic review and meta-analysis

Affiliations
Meta-Analysis

Systemic hormonal contraception initiation after abortion: A systematic review and meta-analysis

Caron Kim et al. Contraception. 2021 May.

Abstract

Background: Immediate contraceptive initiation, including start of a method before abortion completion, is a convenient option for women seeking abortion care.

Objectives: To evaluate the effect of systemic hormonal contraception initiation on medical abortion effectiveness and the safety of hormonal contraceptive methods following abortion.

Data sources: PubMed, Popline, Cochrane Library, and Clinicaltrials.gov.

Study eligibility criteria: Studies that assessed medical abortion effectiveness after systemic hormonal contraception initiation and the safety of hormonal contraception initiation after abortion.

Participants: Pregnant persons undergoing or who had recently undergone an abortion.

Interventions: Initiation of systemic hormonal contraception post abortion or on the day of the first pill of the medical abortion.

Study appraisal and synthesis methods: We assessed study quality using the US Preventive Services Task Force evidence grading system. We created narrative summaries and calculated pooled relative risks when appropriate.

Results: We identified 16 studies for inclusion, 7 randomized controlled trials, and 9 cohorts. Nine studies assessed medical abortion effectiveness with hormonal contraception initiation and generally found no decreased risk of abortion success or increased risk of additional treatment. One fair-quality study reported a small increase in ongoing pregnancy rate with immediate depot medroxyprogesterone (DMPA) compared with delayed DMPA initiation (3.6% vs 0.9%, risk difference 2.7%, 90% confidence interval 0.4-5.6). We identified no bleeding-related safety concerns following hormonal contraception initiation after medical or surgical abortion. Pooled results were too imprecise to draw firm conclusions.

Limitations: Included studies were poor or fair quality and primarily in high-income or upper-middle-income settings.

Conclusions: Abortion effectiveness did not differ between immediate vs delayed initiation of most systemic hormonal contraceptive methods after a first trimester medical abortion. However, immediate DMPA initiation did show increased ongoing pregnancy. Bleeding effects with hormonal contraception initiation postabortion appeared minimal.

Implications: Initiating a hormonal contraceptive method after an abortion and as early as the same day as the first pill of the medical abortion is an option if contraception is desired. The slight increase in ongoing pregnancy with immediate DMPA initiation highlights the importance of information provision during contraceptive counseling.

Keywords: Abortion; Contraception; Delayed; Hormonal; Immediate; Medical abortion effectiveness; Systematic review.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
Identification of included studies.
Fig 2
Fig. 2
Pooled estimate of unadjusted odds ratio for need of surgery to complete abortion among individuals* initiating immediate vs delayed etonogestrel implant insertion after a medical abortion. *Denominators based on intention-to-treat analysis.
Fig 3
Fig. 3
Pooled estimate of unadjusted odds ratio for need of additional medical treatment* among individuals+ initiating immediate vs delayed etonogestrel implant insertion after a medical abortion. *Only includes individuals who required additional medical treatment but did not require surgery to complete the abortion. +Denominators based on intention-to-treat analysis.
Fig 4
Fig. 4
Pooled estimate of unadjusted odds ratios for abortion success* among individuals+ initiating combined oral contraception (COC) vs placebo after a medical abortion. *Defined as no need for surgery to complete abortion. +Denominators based on intention-to-treat analysis.

References

    1. Lahteenmaki P, Luukkainen T. Return of ovarian function after abortion. Clin Endocrinol (Oxf) 1978;8:123–132. - PubMed
    1. Boyd Jr EF, Holmstrom EG. Ovulation following therapeutic abortion. Am J Obstet Gynecol. 1972;113:469–473. - PubMed
    1. Donnet ML, Howie PW, Marnie M, Cooper W, Lewis M. Return of ovarian function following spontaneous abortion. Clin Endocrinol (Oxf) 1990;33:13–20. - PubMed
    1. Schreiber CA, Sober S, Ratcliffe S, Creinin MD. Ovulation resumption after medical abortion with mifepristone and misoprostol. Contraception. 2011;84:230–233. - PubMed
    1. Boesen HC, Rorbye C, Norgaard M, Nilas L. Sexual behavior during the first eight weeks after legal termination of pregnancy. Acta Obstet Gynecol Scand. 2004;83:1189–1192. - PubMed

Publication types